{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:10:50Z","timestamp":1795065050563,"version":"4.10.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Purpose of this study is to evaluate the diagnostic accuracy of quantitative T2\/ADC values in differentiating between PCa and lesions showing non-specific inflammatory infiltrates and atrophy, features of chronic prostatitis, as the most common histologically proven differential diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective, single-center cohort study, we analyzed 55 patients suspected of PCa, who underwent mpMRI (3T) including quantitative T2 maps before robot-assisted mpMRI-TRUS fusion prostate biopsy. All prostate lesions were scored according to PI-RADS v2.1. Regions of interest (ROIs) were annotated in focal lesions and normal prostate tissue. Quantitative mpMRI values from T2 mapping and ADC were compared using two-tailed <jats:italic>t<\/jats:italic> tests. Receiver operating characteristic curves (ROCs) and cutoff were calculated to differentiate between PCa and chronic prostatitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Focal lesions showed significantly lower ADC and T2 mapping values than normal prostate tissue (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). PCa showed significantly lower ADC and T2 values than chronic prostatitis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). ROC analysis revealed areas under the receiver operating characteristic curves (AUCs) of 0.85 (95% CI 0.74\u20130.97) for quantitative ADC values and 0.84 (95% CI 0.73\u20130.96) for T2 mapping. A significant correlation between ADC and T2 values was observed (<jats:italic>r<\/jats:italic>\u2009=\u20090.70; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>T2 mapping showed high diagnostic accuracy for differentiating between PCa and chronic prostatitis, comparable to the performance of ADC values.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-022-03991-8","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:21:23Z","timestamp":1648732883000},"page":"1455-1461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["T2 mapping for the characterization of prostate lesions"],"prefix":"10.1007","volume":"40","author":[{"given":"Tobias","family":"Hepp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kalmbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Martirosian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang M.","family":"Thaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Notohamiprodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2778-3108","authenticated-orcid":false,"given":"Jens","family":"Bedke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"issue":"4","key":"3991_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225\u2013249. https:\/\/doi.org\/10.3322\/caac.20006","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"3991_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1055\/s-0035-1553162","volume":"187","author":"T Franiel","year":"2015","unstructured":"Franiel T, Asbach P, Teichgraber U, Hamm B, Foller S (2015) Prostate imaging\u2014an update. Rofo 187(9):751\u2013759. https:\/\/doi.org\/10.1055\/s-0035-1553162","journal-title":"Rofo"},{"issue":"2","key":"3991_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00330-013-3017-5","volume":"24","author":"MC Roethke","year":"2014","unstructured":"Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M, Schlemmer HP, Hadaschik BA (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR\/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24(2):344\u2013352. https:\/\/doi.org\/10.1007\/s00330-013-3017-5","journal-title":"Eur Radiol"},{"issue":"4","key":"3991_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00345-015-1655-8","volume":"34","author":"S Kaufmann","year":"2016","unstructured":"Kaufmann S, Bedke J, Gatidis S, Hennenlotter J, Kramer U, Notohamiprodjo M, Nikolaou K, Stenzl A, Kruck S (2016) Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer. World J Urol 34(4):509\u2013515. https:\/\/doi.org\/10.1007\/s00345-015-1655-8","journal-title":"World J Urol"},{"issue":"2","key":"3991_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/1754-9485.12555","volume":"61","author":"R Jyoti","year":"2017","unstructured":"Jyoti R, Jina NH, Haxhimolla HZ (2017) In-gantry MRI guided prostate biopsy diagnosis of prostatitis and its relationship with PIRADS vol 2 based score. J Med Imaging Radiat Oncol 61(2):212\u2013215. https:\/\/doi.org\/10.1111\/1754-9485.12555","journal-title":"J Med Imaging Radiat Oncol"},{"key":"3991_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-5956-12-32","volume":"12","author":"S Bergamini","year":"2014","unstructured":"Bergamini S, Bellei E, Reggiani Bonetti L, Monari E, Cuoghi A, Borelli F, Sighinolfi MC, Bianchi G, Ozben T, Tomasi A (2014) Inflammation: an important parameter in the search of prostate cancer biomarkers. Proteome Sci 12:32. https:\/\/doi.org\/10.1186\/1477-5956-12-32","journal-title":"Proteome Sci"},{"issue":"3","key":"3991_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/modpathol.3800055","volume":"17","author":"JR Srigley","year":"2004","unstructured":"Srigley JR (2004) Benign mimickers of prostatic adenocarcinoma. Mod Pathol 17(3):328\u2013348. https:\/\/doi.org\/10.1038\/modpathol.3800055","journal-title":"Mod Pathol"},{"issue":"5","key":"3991_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jmri.23860","volume":"37","author":"JV Hegde","year":"2013","unstructured":"Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, Tempany CM (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37(5):1035\u20131054. https:\/\/doi.org\/10.1002\/jmri.23860","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"3991_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1148\/radiol.2015151089","volume":"279","author":"GJ Metzger","year":"2016","unstructured":"Metzger GJ, Kalavagunta C, Spilseth B, Bolan PJ, Li X, Hutter D, Nam JW, Johnson AD, Henriksen JC, Moench L, Konety B, Warlick CA, Schmechel SC, Koopmeiners JS (2016) Detection of prostate cancer: quantitative multiparametric MR imaging models developed using registered correlative histopathology. Radiology 279(3):805\u2013816. https:\/\/doi.org\/10.1148\/radiol.2015151089","journal-title":"Radiology"},{"issue":"1","key":"3991_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1148\/radiol.2016151406","volume":"280","author":"A Hoang Dinh","year":"2016","unstructured":"Hoang Dinh A, Melodelima C, Souchon R, Lehaire J, Bratan F, Mege-Lechevallier F, Ruffion A, Crouzet S, Colombel M, Rouviere O (2016) Quantitative analysis of prostate multiparametric MR images for detection of aggressive prostate cancer in the peripheral zone: a multiple imager study. Radiology 280(1):117\u2013127. https:\/\/doi.org\/10.1148\/radiol.2016151406","journal-title":"Radiology"},{"issue":"4","key":"3991_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.diii.2014.11.016","volume":"96","author":"A Hoang Dinh","year":"2015","unstructured":"Hoang Dinh A, Souchon R, Melodelima C, Bratan F, Mege-Lechevallier F, Colombel M, Rouviere O (2015) Characterization of prostate cancer using T2 mapping at 3T: a multi-scanner study. Diagn Interv Imaging 96(4):365\u2013372. https:\/\/doi.org\/10.1016\/j.diii.2014.11.016","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"3991_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/rli.0000000000000520","volume":"54","author":"J Mai","year":"2019","unstructured":"Mai J, Abubrig M, Lehmann T, Hilbert T, Weiland E, Grimm MO, Teichgraber U, Franiel T (2019) T2 Mapping in prostate cancer. Invest Radiol 54(3):146\u2013152. https:\/\/doi.org\/10.1097\/rli.0000000000000520","journal-title":"Invest Radiol"},{"issue":"2","key":"3991_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jmri.25972","volume":"48","author":"T Hilbert","year":"2018","unstructured":"Hilbert T, Sumpf TJ, Weiland E, Frahm J, Thiran JP, Meuli R, Kober T, Krueger G (2018) Accelerated T(2) mapping combining parallel MRI and model-based reconstruction: GRAPPATINI. J Magn Reson Imaging 48(2):359\u2013368. https:\/\/doi.org\/10.1002\/jmri.25972","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"3991_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00345-016-1970-8","volume":"35","author":"S Kaufmann","year":"2017","unstructured":"Kaufmann S, Mischinger J, Amend B, Rausch S, Adam M, Scharpf M, Fend F, Kramer U, Notohamiprodjo M, Nikolaou K, Stenzl A, Bedke J, Kruck S (2017) First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy. World J Urol 35(7):1023\u20131029. https:\/\/doi.org\/10.1007\/s00345-016-1970-8","journal-title":"World J Urol"},{"issue":"1","key":"3991_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2214\/ajr.13.10699","volume":"202","author":"AB Rosenkrantz","year":"2014","unstructured":"Rosenkrantz AB, Taneja SS (2014) Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 202(1):109\u2013120. https:\/\/doi.org\/10.2214\/ajr.13.10699","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"3991_CR16","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/mrm.26816","volume":"79","author":"PJ van Houdt","year":"2018","unstructured":"van Houdt PJ, Agarwal HK, van Buuren LD, Heijmink S, Haack S, van der Poel HG, Ghobadi G, Pos FJ, Peeters JM, Choyke PL, van der Heide UA (2018) Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T(2) mapping across multiple systems. Magn Reson Med 79(3):1586\u20131594. https:\/\/doi.org\/10.1002\/mrm.26816","journal-title":"Magn Reson Med"},{"issue":"5","key":"3991_CR17","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/mrm.22874","volume":"65","author":"W Liu","year":"2011","unstructured":"Liu W, Turkbey B, Senegas J, Remmele S, Xu S, Kruecker J, Bernardo M, Wood BJ, Pinto PA, Choyke PL (2011) Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med 65(5):1400\u20131406. https:\/\/doi.org\/10.1002\/mrm.22874","journal-title":"Magn Reson Med"},{"issue":"1","key":"3991_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.acra.2018.04.005","volume":"26","author":"A Chatterjee","year":"2019","unstructured":"Chatterjee A, Devaraj A, Mathew M, Szasz T, Antic T, Karczmar GS, Oto A (2019) Performance of T2 maps in the detection of prostate cancer. Acad Radiol 26(1):15\u201321. https:\/\/doi.org\/10.1016\/j.acra.2018.04.005","journal-title":"Acad Radiol"},{"issue":"4","key":"3991_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.mri.2008.08.001","volume":"27","author":"JR Roebuck","year":"2009","unstructured":"Roebuck JR, Haker SJ, Mitsouras D, Rybicki FJ, Tempany CM, Mulkern RV (2009) Carr\u2013Purcell\u2013Meiboom\u2013Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination. Magn Reson Imaging 27(4):497\u2013502. https:\/\/doi.org\/10.1016\/j.mri.2008.08.001","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"3991_CR20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/mrm.1298","volume":"46","author":"P Gibbs","year":"2001","unstructured":"Gibbs P, Tozer DJ, Liney GP, Turnbull LW (2001) Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46(6):1054\u20131058. https:\/\/doi.org\/10.1002\/mrm.1298","journal-title":"Magn Reson Med"},{"key":"3991_CR21","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.18.20536","author":"MD Greer","year":"2019","unstructured":"Greer MD, Shih JH, Lay N, Barrett T, Bittencourt L, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B (2019) Interreader variability of prostate imaging reporting and data system version 2 in detecting and assessing prostate cancer lesions at prostate MRI. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/ajr.18.20536","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"3991_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.mri.2015.02.006","volume":"33","author":"FI Yamauchi","year":"2015","unstructured":"Yamauchi FI, Penzkofer T, Fedorov A, Fennessy FM, Chu R, Maier SE, Tempany CM, Mulkern RV, Panych LP (2015) Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence. Magn Reson Imaging 33(5):525\u2013530. https:\/\/doi.org\/10.1016\/j.mri.2015.02.006","journal-title":"Magn Reson Imaging"},{"issue":"10","key":"3991_CR23","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1007\/s00330-018-5374-6","volume":"28","author":"MD Greer","year":"2018","unstructured":"Greer MD, Lay N, Shih JH, Barrett T, Bittencourt LK, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Mertan FV, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B (2018) Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader study. Eur Radiol 28(10):4407\u20134417. https:\/\/doi.org\/10.1007\/s00330-018-5374-6","journal-title":"Eur Radiol"},{"issue":"3","key":"3991_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1148\/radiol.2019182843","volume":"293","author":"M Roux","year":"2019","unstructured":"Roux M, Hilbert T, Hussami M, Becce F, Kober T, Omoumi P (2019) MRI T2 mapping of the knee providing synthetic morphologic images: comparison to conventional turbo spin-echo MRI. Radiology 293(3):620\u2013630. https:\/\/doi.org\/10.1148\/radiol.2019182843","journal-title":"Radiology"},{"key":"3991_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27297","author":"S Li","year":"2020","unstructured":"Li S, Liu J, Zhang F, Yang M, Zhang Z, Liu J, Zhang Y, Hilbert T, Kober T, Cheng J, Zhu J (2020) Novel T2 mapping for evaluating cervical cancer features by providing quantitative T2 maps and synthetic morphologic images: a preliminary study. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.27297","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"3991_CR26","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1148\/radiol.2493080236","volume":"249","author":"DL Langer","year":"2008","unstructured":"Langer DL, van der Kwast TH, Evans AJ, Sun L, Yaffe MJ, Trachtenberg J, Haider MA (2008) Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2\u2014sparse versus dense cancers. Radiology 249(3):900\u2013908. https:\/\/doi.org\/10.1148\/radiol.2493080236","journal-title":"Radiology"},{"issue":"8","key":"3991_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.acra.2014.04.007","volume":"21","author":"LM Wu","year":"2014","unstructured":"Wu LM, Chen XX, Xuan HQ, Liu Q, Suo ST, Hu J, Xu JR (2014) Feasibility and preliminary experience of quantitative T2* mapping at 3.0 T for detection and assessment of aggressiveness of prostate cancer. Acad Radiol 21(8):1020\u20131026. https:\/\/doi.org\/10.1016\/j.acra.2014.04.007","journal-title":"Acad Radiol"},{"issue":"9","key":"3991_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/RLI.0b013e3181b4c10e","volume":"44","author":"P Gibbs","year":"2009","unstructured":"Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW (2009) Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Investig Radiol 44(9):572\u2013576. https:\/\/doi.org\/10.1097\/RLI.0b013e3181b4c10e","journal-title":"Investig Radiol"},{"issue":"2","key":"3991_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2214\/ajr.07.2211","volume":"189","author":"MA Haider","year":"2007","unstructured":"Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, Trachtenberg J (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189(2):323\u2013328. https:\/\/doi.org\/10.2214\/ajr.07.2211","journal-title":"AJR Am J Roentgenol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-03991-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-022-03991-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-03991-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T14:08:11Z","timestamp":1654265291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-022-03991-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3991"],"URL":"https:\/\/doi.org\/10.1007\/s00345-022-03991-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tom Hilbert is employed by Siemens Healthcare, Switzerland. All other authors disclose no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Hospital T\u00fcbingen (359\/2019BO2).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}